Penserra Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

$4.61 Billion
Q3 2024

A detailed history of Penserra Capital Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Penserra Capital Management LLC holds 21 shares of VRTX stock, worth $9,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 21 -0.0%

Holding current value

$9,470

Previous $10,000 10.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $686,957 - $751,644	-1,685 Reduced 98.77%	21 $8,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $56,252 - $67,351	164 Added 10.64%	1,706 $693,000
Q3 2023 Nov 15, 2023	SELL	$338.18 - $362.46 $151,504 - $162,382	-448 Reduced 22.51%	1,542 $535,000
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $31,756 - $35,542	-101 Reduced 4.83%	1,990 $698,000
Q1 2023 Apr 24, 2023	BUY	$283.23 - $323.1 $554,281 - $632,306	1,957 Added 1460.45%	2,091 $657,000
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $3.56 Million - $4.01 Million	-12,471 Reduced 98.94%	134 $38,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $847,230 - $945,309	-3,094 Reduced 19.71%	12,605 $3.65 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $1.71 Million - $2.12 Million	-7,263 Reduced 31.63%	15,699 $4.42 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $5.06 Million - $5.96 Million	22,836 Added 18123.81%	22,962 $5.99 Million
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $1,062 - $1,340	6 Added 5.0%	126 $27,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $5,441 - $6,089	30 Added 33.33%	120 $21,000
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $16,874 - $19,899	90 New	90 $18,000
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $885,631 - $1.03 Million	-4,278 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $1.96 Million - $2.61 Million	-9,449 Reduced 68.84%	4,278 $1.01 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $3.11 Million - $3.69 Million	-12,173 Reduced 47.0%	13,727 $3.74 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $5.54 Million - $7.26 Million	24,550 Added 1818.52%	25,900 $7.52 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $269,689 - $334,543	1,350 New	1,350 $366,000
Q3 2018 Nov 05, 2018	SELL	$167.73 - $192.74 $2.18 Million - $2.51 Million	-13,005 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $1.9 Million - $2.21 Million	13,005 New	13,005 $2.21 Million
Q3 2017 Oct 26, 2017	SELL	$148.13 - $162.24 $1.53 Million - $1.68 Million	-10,353 Closed	0 $0
Q2 2017 Aug 21, 2017	BUY	N/A	10,353	10,353 $1.33 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Account

Penserra Capital Management LLC Vertex Pharmaceuticals Inc Transaction History